Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 00973Y108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 0.00 · Class: 0%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 0.00 · Class: 0%
- David Kroin
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-000709
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership